Abstract
Background Core patient characteristic sets (CPCS) are increasingly developed to identify variables that should be reported to describe the target population of epidemiological studies in the same medical area, while keeping the additional burden on the data collection acceptable.
Methods We conduct a systematic review of primary studies/ protocols published aiming to develop CPCS, using the PubMed database. We particularly focus on the study design and the characteristics of the proposed CPCS. Quality of Delphi studies was assessed by a tool prosposed in the literatue. All results are reported descriptively.
Results Among 23 eligible studies, Delphi survey is the most frequently used technique to obtain consensus in CPCS development (69.6%, n=16). Most studies do not include patients as stakeholders. The final CPCS rarely include socioeconomic factors. 60.9% (n=14) and 31.6% (n=6) of studies provide definition and recommend measurement methods for items, respectively.
Conclusion This study identified a considerable variation and suboptimality in many methodological aspects of CPCS studies. To enhance the credibility and adoption of CPCS, a standard for conducting and reporting CPCS studies is warranted.
Funding No funds, grants, or other support were received during the preparation of this manuscript.
Registration This review was not pre-registered.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: Myluong.1710{at}gmail.com. Tel: 32 485 46 16 31.
Email: trang.tu{at}uantwerpen.be. Tel: 32 486977358.
Email: 202160462{at}o.cnu.ac.kr. Tel: 82 10 3928 3663.
Email: tatthang{at}wharton.upenn.edu. Tel: 215 898 8222.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
